Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Dermatology | Endocrinology | Family Medicine | Geriatrics | Gastroenterology | Gynecology | Infections | AIDS | Internal Medicine | Allergy | Critical Care | Emergency Medicine | Nephrology | Neurology | Nursing | Oncology | Ophthalmology | Orthopedics | ENT | Pathology | Pediatrics | Pharmacy | Psychiatry | Pulmonology | Radiology | Rheumatology | Surgery | Anesthesiology & Pain | Urology | Journal

Back to Journal Articles

Buprenorphine Maintenance Therapy Not Recommended

Last Updated: March 08, 2012.

 

Abstinence-based therapy recommended instead for opioid-addicted health care professionals

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Opioid substitution therapy with buprenorphine is not recommended for opioid-addicted health care professionals, according to research published in the March issue of the Mayo Clinic Proceedings.

THURSDAY, March 8 (HealthDay News) -- Opioid substitution therapy with buprenorphine is not recommended for opioid-addicted health care professionals (HCPs), according to research published in the March issue of the Mayo Clinic Proceedings.

Heather Hamza, C.R.N.A., of the Los Angeles County Medical Center, and Ethan O. Bryson, M.D., of the Mount Sinai Medical Center in New York City, reviewed the literature on buprenorphine maintenance therapy in opioid-addicted HCPs who return to clinical practice after drug addiction treatment. Specifically, the authors reviewed the pharmacology of buprenorphine, its abuse potential and neurocognitive effects, and state-specific recommendations regarding the rehabilitation of opioid-addicted HCPs.

Given the safety-sensitive work that these HCPs perform and the potential consequences of errors, the authors recommend the use of abstinence-based recovery programs until studies demonstrate the safety of using buprenorphine substitution in this population. Most studies evaluating the effects of buprenorphine identified some degree of impairment in higher cerebral functioning. The majority of state programs responding to a survey performed by the authors indicated that they used an abstinence-based model for rehabilitating opioid-addicted HCPs.

"The foundation information required to make good decisions regarding this medication in this population working in safety-sensitive positions is lacking," write the authors of an accompanying editorial. "The use of a medication that has the potential to undermine cognitive function in HCPs working in an emergency or critical patient care setting cannot be supported at this time, given the lack of evidence of efficacy in this population and the absence of adequate national standards for use."

Abstract
Full Text
Editorial

Copyright © 2012 HealthDay. All rights reserved.


Previous: Misoprostol Cuts Complications in First-Trimester Abortion Next: Tibial Trabecular Bone Texture Predicts OA Progression

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.